Univdatos Whatsapp

Global Antinuclear Antibody Test Market Is Expected To Foresee Significant Growth During The Forecast Period. North America to Witness the Highest Growth

The Global Antinuclear Antibody Test Market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 12% during the forecast period (2021-2027F). Antibodies are proteins that the immune system forms to fight bacteria, viruses, and pathogens. sometimes, the immune system can mistake parts of its own body for foreign bodies. It releases special antibodies, known as autoantibodies that attack its own body cells and tissues.

The rising prevalence of autoimmune diseases and increasing malnutrition in developing as well as in underdeveloped nations are the reason for the increasing demand for the diagnosis of autoimmune diseases which results in an increasing market size for antinuclear antibody tests. For instance, according to the national institute of environmental health sciences, autoimmune diseases affect more than 24 million people in the United States. Furthermore, the increasing focus on R&D is also catalyzing the market growth of the antinuclear antibody test.

For a detailed analysis of the market drivers of antinuclear antibody tests browse through – https://univdatos.com/report/antinuclear-antibody-test-market/

Based on the product, the market is categorized into reagents & assay kits, systems, software & services. The reagents & assay kits segment grabbed major market share in the growth hormone drug market in 2020. This is mainly due to the high adoption of the reagents & assay kits in the clinical and research facilities. Furthermore, the reagents are used in the diagnosis and help professionals achieve accurate and efficient results.

Based on the technique, the market is categorized into ELISA, immunofluorescence assay, and multiplex assay. The ELISA category is anticipated to witness significant growth during the forecast period. The ELISA is antigen-antibody interaction. Here, the specific antibodies associate or bind to their target antigen. Only when the interaction takes place, the substrate can bind to the enzyme, thereby substrate conversion can be observed, and hence a positive result is obtained. Furthermore, the high specificity and accuracy of the technique enable the ELISA to have a significant market share in the forecast period.

Based on the application, the market is categorized into rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s syndrome, scleroderma, and others. The rheumatoid arthritis segment grabbed major market share in the growth hormone drug market in 2020. This is mainly due to the rising prevalence of rheumatoid arthritis For instance, as per Healthline, out of every 100,000 people, 71 are diagnosed with rheumatoid arthritis every year and about 1.5 million Americans have rheumatoid arthritis.

For a detailed analysis of the market drivers of antinuclear antibody tests browse through – https://univdatos.com/report/antinuclear-antibody-test-market/

Based on the end-users, the market is categorized as hospitals & clinics, diagnostic centers, and others. The hospitals & clinics category is anticipated to witness significant growth during the forecast period. the presence of well-qualified professionals and their specialization in the treatment of multiple diseases. Furthermore, the rising number of anti-immune diseases and the presence of diagnostic facilities under the same roof is responsible for the segmental growth in the antinuclear antibody test market. For instance, as per MedlinePlus, the prevalence of systemic scleroderma is estimated to range from 50 to 300 cases per 1 million people.

Additionally, the report provides detailed report also provides insights into the global antinuclear antibody test market according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a significant market for the non-woven gloves industry. The presence of sophisticated healthcare infrastructure and the higher healthcare expenditure in the region is responsible for the significant market share of the region in the antinuclear antibody test market. For instance, the per person annual healthcare expenditure of Canada accounted for US$ 3,541.25 in 2016 which rose by around 9% in 2019 and reached US$ 3,873.7.

Request for a Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=25128

Zeus Scientific Inc., Antibodies Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, ERBA Diagnostics Inc., EUROIMMUN AG, Trinity Biotech plc, Alere Inc., Inova Diagnostics, and Immuno Concepts. are some of the key players operating in the global Antinuclear antibody test market. Several M&As along with partnerships have been undertaken by these players to develop various types of Antinuclear antibody tests.

Global Antinuclear Antibody Test Market Segmentation

Market Insight, by Product

• Reagents & Assay Kits
• Systems
• Software & Services

Market Insight, by Technique

• ELISA
• Immunofluorescence Assay
• Multiplex Assay

Market Insight, by Application

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjogren’s Syndrome
• Scleroderma
• Others

Market Insight, by End-user

• Hospitals & Clinics
• Diagnostic Centers
• Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Australia
    • Japan
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

• Zeus Scientific Inc.
• Antibodies Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• ERBA Diagnostics Inc.
• EUROIMMUN AG
• Trinity Biotech plc
• Alere Inc.
• Inova Diagnostics
• Immuno Concepts

Leave A Comment

Select Language